Uppsala Monitoring Centre

30/08/2026

Putting into practice 🌱

Mexico🇲🇽 is implementing new measures to integrate medication and medical device management and related waste streams. Through stricter controls on storage, transport, treatment, destruction, and documentation, the framework aims to reduce contamination of water, soil, and ecosystems while simultaneously limiting opportunities for medicine diversion, misuse, and illegal recycling.

Learn how regulatory action can support both and environmental in at the link below👇

Mexico's new pharmaceutical waste framework puts One Health into practice, from hazardous-waste handling in hospitals to expired pills in the kitchen drawer.

27/08/2026

📣 Calling all regulators working in and 📆

Register to attend the 2026 KIDS–APEC Pharmacovigilance Training, held online 10–11 September by the Korea Institute of Drug Safety and Risk Management (KIDS).

This two-day virtual event covers a wide range of topics in PV, including regulatory science, PV inspection, digital innovation, risk management, and real-world evidence. It also features presentations by UMC's Angnis Schmidt-May and Carlos Melgarejo González on AI in PV and signal detection.

📆 11–10 September 2026
🖥️ Online
❗️Registration ends 31 August 2026

Learn more about this training and register to attend via this link 👉 https://kidscoe.drugsafe.or.kr

26/08/2026

⏱️ The countdown is on to !

UMC will be on-site exhibiting, instructing, and presenting from 22–25 September in San José, Costa Rica🇨🇷.

From signal management to standardisation, , PV , and more, UMC colleagues will touch on an array of topics that explore ecosystems of trust within .

📆 Explore what's on the agenda in the photos below 👇

Visit the conference website for the full programme and event details 👉 https://www.isop2026costarica.org/

24/08/2026

Are you attending in Milan?

Be sure to join Niklas Norén for a pre-conference course on and signal detection to gain insight into statistical methods for signal detection using individual case reports.

📆 Saturday, 29 August
🕝 14:30–18:00 CEST
📍 Allianz Milan Convention Centre, Milan, Italy 🇮🇹

UMC will also have 3 new scientific posters on display during Poster Session B covering several exciting topics in research:
• Not all reports are created equal: Misclassification in pharmacovigilance case identification (B-337)
• Rule-based flagging of indication-related biases in crude disproportionality signals to support expert triage (B-338)
• Application of Tree-Based Scan Statistics for Hierarchical Signal Detection in VigiBase (B-339)

We look forward to seeing you there! 👋

Access all information about the 42nd ISPE Annual Meeting here 👉 https://ispe2026.eventscribe.net/

21/08/2026

When reporting is made easier, it gets done. That's what two hospitals in Sydney, Australia, experienced after an automated ADR reporting tool was introduced into their electronic medical records (EMR) systems

For years, Blacktown and Mt Druitt Hospitals submitted almost no ADR reports to Australia’s medicines regulator. Thanks to the automated system taking on more routine work, this number increased to over 1,600.

Jing Xin Goh and Ronald L Castelino explain how the tool is helping to break down reporting barriers and set a model for the future of medicines safety reporting.

📖 Explore the key findings of their article in the images below👇 and read the on 👉 https://ow.ly/xch950ZBVTk

20/08/2026

🎧 Looking for the latest from the world of medicines safety?

Listen to the podcast for expert insight into trending topics, new research, and more:

🌱 Ecopharmacovigilance and
🔎 Disproportionality analyses
🩻 Medical devices

Tune in online or via your favourite podcast player 👉 https://www.drugsafetymatterspod.org

19/08/2026

Are you interested in learning more about safe care for noncommunicable diseases?

Join ISoP Online for their free online event, , from 17–18 September 2026📆

Register now to join an online session in your region of the world via the post below 👇

🎉 Registration is now OPEN for ISoP Patient Safety Day 2026!

Join us on 17–18 September 2026 for this free online event, where experts from around the world will come together to explore this year's theme: "Safe Care for Noncommunicable Diseases"

Patient Safety Day provides a unique opportunity to learn, exchange ideas, and discuss practical approaches to improving medicine safety and patient care across healthcare systems.

🔗 Register now: https://us02web.zoom.us/meeting/register/tQykJHFWSOmNm04APJ5lbQ

📅 Stay tuned! Over the coming days, we'll be sharing the full agenda, speaker highlights, and more details about the sessions you won't want to miss.

We look forward to seeing you online!

16/08/2026

Our global family is growing – welcome to Belize🇧🇿 who joins the World Health Organization (WHO) Programme for International Drug Monitoring (PIDM) as the 162nd member! 🎉

The WHO PIDM provides a forum for WHO member states, territories, and areas to work together to improve medicines and vaccine safety. By sharing national insights, members help strengthen safety surveillance around the world.

Read more about the WHO PIDM at this link 👉 ow.ly/LRxp50FnvQV

And explore our film series 'The WHO PIDM in Focus' to gain insight into the work that UMC, WHO, and members do to ensure the safety of patients worldwide here 👉 ow.ly/j81o50QPVtJ

13/08/2026

🎥 What does mean to you?

Each year, we partner with stakeholders worldwide to raise awareness of and encourage the reporting of suspected side effects. We asked our colleagues in Belgium🇧🇪 to share their Med Safety Story and how the campaign empowers people to act, report, and help make medicines safer for everyone.

Olivier Christiaens of Agence fédérale des médicaments et des produits de santé tells us how medicines safety benefits from this collective commitment in the film below👇

📆 Join us from 2 to 8 November 2026 as we explore why we should report and not ignore side effects. Learn more 👉 http://ow.ly/XEoc50LlhaJ

11/08/2026

Do you want to learn more about global safety surveillance? Join a pre-conference course at 🇨🇷

FDA's and UMC's will be the focus of this half-day course, designed for pharmacovigilance professionals interested in post-market drug safety monitoring. Attendees will gain practical insight into the frameworks of both databases, reporting patterns over time, methods for identifying special populations in adverse event data, practical applications in global , and much more.

📆 Tuesday, 22 September
🕗 Half-day course

Learn more about the course content in the images below 👇 and register to attend the ISoP Online Global Meeting on the conference website 🌐 https://www.isop2026costarica.org/

With support from Monica Monuz (FDA) Leah B Herity (FDA), Michele Fusaroli, Niklas Norén, and Levente Pápai (UMC)